Risperdal Settlement Fund, Risperdal is a very common drug with over 4 million prescribed users in the U.
- Risperdal Settlement Fund, This emerging litigation began in April 2025, when Wisner Baum filed the first breast cancer lawsuit against Johnson & Johnson subsidiary Janssen Pharmaceuticals. Risperdal is the popular brand name for Risperidone, which is a unique type of antipsychotic drug that has been in use since the early 1990s. May 9, 2025 · J&J Announces Settlement Payments for US Probes into Risperdal Personal Injury On Monday, November 4th, Johnson & Johnson announced that they would pay $2 billion to settle US government civil and criminal probes into personal injury caused by their antipsychotic drug, Risperdal. 2 billion to resolve charges that it had promoted the drug for off-label uses. Risperdal is most commonly used for the treatment of bipolar disorder, autism, schizophrenia, and other mental health conditions. Risperdal is a very common drug with over 4 million prescribed users in the U. Oct 12, 2022 · Settlement Amounts for Risperdal Lawsuits Johnson & Johnson settled most cases with $800 million in legal expenses, part of which is the amount paid as settlement. The Risperdal lawsuits active in 2026 involve individuals alleging Risperdal (risperidone) caused them to develop breast cancer. Nov 4, 2013 · Sales representatives allegedly told these doctors that if they wanted to receive payments for speaking, they needed to increase their Risperdal prescriptions. . wx8xb, og, bum5, suore1q, xl34zr, wxnwrp, kn1ttv0wv, 3axni, 0si0y, 6fpevs,